BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6222930)

  • 1. Long-acting progestins--promise and prospects.
    Popul Rep K; 1983 May; 11(2):K17-55. PubMed ID: 6222930
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of steroids for incorporation into silastic intrauterine devices.
    Doyle LL; Stryker JC; Clewe TH; Harrison RA
    J Steroid Biochem; 1975 Jun; 6(6):885-8. PubMed ID: 809619
    [No Abstract]   [Full Text] [Related]  

  • 3. New delivery systems for hormonal contraception.
    Odlind V
    Acta Obstet Gynecol Scand Suppl; 1986; 134():15-20. PubMed ID: 2949479
    [No Abstract]   [Full Text] [Related]  

  • 4. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 5. Long acting injectable hormonal contraceptives.
    Fraser IS
    Clin Reprod Fertil; 1982 Mar; 1(1):67-88. PubMed ID: 6226351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal contraception using depot preparations].
    Keller PJ
    Ther Umsch; 1986 May; 43(5):395-9. PubMed ID: 2941890
    [No Abstract]   [Full Text] [Related]  

  • 7. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    Levine JP
    J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modern methods of regulating fertility].
    Sleptsova SI
    Akush Ginekol (Mosk); 1980 Oct; (10):5-8. PubMed ID: 7004228
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-acting progestogen-only contraceptive injections: an update.
    Bhathena RK
    BJOG; 2001 Jan; 108(1):3-8. PubMed ID: 11213001
    [No Abstract]   [Full Text] [Related]  

  • 10. Progestins for contraception: modern delivery systems and novel formulations.
    Royer PA; Jones KP
    Clin Obstet Gynecol; 2014 Dec; 57(4):644-58. PubMed ID: 25314087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    Fraser IS; Weisberg E
    Med J Aust; 1981 Jan; 1(SP1):3-19. PubMed ID: 6453269
    [No Abstract]   [Full Text] [Related]  

  • 13. New regimen of injectable contraceptives.
    Chinvanthannond P; Samransamruajkit S
    J Med Assoc Thai; 1987 Apr; 70(4):198-203. PubMed ID: 2956352
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenopausal hormone replacement therapy and plasma lipoproteins.
    Taskinen MR
    J Intern Med; 1995 Nov; 238(5):385-7. PubMed ID: 7595177
    [No Abstract]   [Full Text] [Related]  

  • 16. Contraceptives: a look at the future.
    Monier M; Laird M
    Am J Nurs; 1989 Apr; 89(4):496-9. PubMed ID: 2523195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of menstrual blood loss with progestagen-releasing intrauterine devices].
    Pedrón N; González Diddí M; Alvarado Durán A; Gallegos A; Aznar R
    Ginecol Obstet Mex; 1981 Jan; 48(291):1-9. PubMed ID: 6791989
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of injectable contraceptives in Mexican women].
    Garza-Flores J; Rodríguez V; Cravioto MC; del Real Mora O; Anderson J; Landeros J; Díaz Sánchez V; Lichtenberg R; Pérez-Palacios G
    Bol Oficina Sanit Panam; 1985 Feb; 98(2):181-6. PubMed ID: 3156612
    [No Abstract]   [Full Text] [Related]  

  • 20. Long acting contraceptives. Present status.
    Benagiano G; Primiero FM
    Drugs; 1983 Jun; 25(6):570-609. PubMed ID: 6223801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.